Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Lexia LLC

US Class II Ongoing · initiated 2026-08-21

CGMP Deviations: Potential contamination of raw material

Golden State Medical Supply Inc.

US Class II Ongoing · initiated 2026-08-21

Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

VITRUVIAS THERAPEUTICS INC

US Class I Ongoing · initiated 2026-08-21

Superpotent Drug

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

Sterling Pharmaceutical Services LLC

US Class II Ongoing · initiated 2026-08-20

Lack of Assurance of Sterility

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

Canada Type III Ongoing · initiated 2026-08-19

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

American Health Packaging

US Class III Ongoing · initiated 2026-08-19

Labeling: Label Mix-up

Chiesi USA, Inc.

US Class III Ongoing · initiated 2026-08-19

Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

B BRAUN MEDICAL INC

US Class I Ongoing · initiated 2026-08-19

Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene

Sage Products, LLC

US Class II Ongoing · initiated 2026-08-18

Cross Contamination with Other Products

Lactated Ringer's Injection USP

Canada Type I Ongoing · initiated 2026-08-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Baxter Healthcare Corporation

US Class I Ongoing · initiated 2026-08-17

Presence of particulate matter: Particulates identified as fiberglass

Mylan Pharmaceuticals Inc

US Class II Ongoing · initiated 2026-08-17

Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

Baxter Healthcare Corporation

US Class I Ongoing · initiated 2026-08-17

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Allies Group Inc.

US Class II Ongoing · initiated 2026-08-14

Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.

Allies Group Inc.

US Class II Ongoing · initiated 2026-08-14

Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.

Allies Group Inc.

US Class II Ongoing · initiated 2026-08-14

Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.

Allies Group Inc.

US Class II Ongoing · initiated 2026-08-14

Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.